Market Overview:
The global ABO blood group reagent market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for blood transfusions and rising prevalence of blood-related disorders. In addition, technological advancements in the field of ABO blood group reagents are also contributing to the growth of this market. On the basis of type, positive identification segment is expected to account for a larger share of the global ABO blood group reagent market during the forecast period. This can be attributed to increasing use of positive identification techniques for accurate determination of ABO and Rh status.
Product Definition:
ABO Blood Group Reagent is a reagent used to determine the ABO blood group. The importance of ABO Blood Group Reagent is that it can help to identify blood types and prevent incompatible transfusions.
Positive Identification:
Positive identification is the process of confirming a sample as that of a known individual. This can be achieved through various techniques such as DNA profiling, fingerprinting, and ABO blood group reagents. Positive identification increases the reliability of an investigation by providing confirmation beyond doubt when several individuals are involved in a crime or accident for instance.
The usage rate for positive identification is high these days due to advancements in technology.
Reverse Identification:
Reverse identification is the process of finding an unknown object or person by using a known object or person as a starting point. In other words, it is used to find out the blood group of an individual by analyzing some part of his/her body such as hair, saliva, urine etc.
Application Insights:
The global market is segmented by application into hospital, blood bank and research. The hospital application segment dominated the market in 2017 owing to an increase in the number of patients suffering from various life-threatening diseases across the globe. According to a study published by WHO, around 730 million people are living with HIV worldwide. Moreover, another study states that around 36 million people are newly infected with hepatitis every year. These statistics show that there is a huge demand for blood products globally and hence will fuel growth over the forecast period.
Blood Bank Application Blood banks play an important role in society as they provide safe storage facilities for donated blood which can be used for therapeutic purposes or emergency situations when donor stem cells are required most rapidly without having to go through a long screening process or waiting list at hospitals etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption of advanced technology and products, and a large number of blood group reagents manufacturers present in this region. Moreover, increasing R&D activities for new product development is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing medical tourism industry and rising awareness about blood donation among people from developing countries such as India & China & Malaysia etc.
Growth Factors:
- Increasing demand for blood transfusion and organ transplantation surgeries
- Rising prevalence of blood disorders and other diseases
- Technological advancements in the field of ABO blood group reagent testing
- Growing awareness about the benefits of early diagnosis and treatment
- Increasing number of research studies on ABO blood group reagents
Scope Of The Report
Report Attributes
Report Details
Report Title
ABO Blood Group Reagent Market Research Report
By Type
Positive Identification, Reverse Identification
By Application
Hospital, Blood Bank, Research, Other
By Companies
CE-Immundiagnostika GmbH, Dominion Biologicals Limited, SHPBC, Brother Biotech, Kinghawk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global ABO Blood Group Reagent Market Report Segments:
The global ABO Blood Group Reagent market is segmented on the basis of:
Types
Positive Identification, Reverse Identification
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Blood Bank, Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CE-Immundiagnostika GmbH
- Dominion Biologicals Limited
- SHPBC
- Brother Biotech
- Kinghawk
Highlights of The ABO Blood Group Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Positive Identification
- Reverse Identification
- By Application:
- Hospital
- Blood Bank
- Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the ABO Blood Group Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
ABO blood group reagent is a type of test used to determine the ABO blood groups of people. This test uses antibodies to specific antigens found on the surface of red blood cells.
Some of the major companies in the abo blood group reagent market are CE-Immundiagnostika GmbH, Dominion Biologicals Limited, SHPBC, Brother Biotech, Kinghawk.
The abo blood group reagent market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 ABO Blood Group Reagent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 ABO Blood Group Reagent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 ABO Blood Group Reagent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the ABO Blood Group Reagent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global ABO Blood Group Reagent Market Size & Forecast, 2020-2028
4.5.1 ABO Blood Group Reagent Market Size and Y-o-Y Growth
4.5.2 ABO Blood Group Reagent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Positive Identification
5.2.2 Reverse Identification
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Blood Bank
6.2.3 Research
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global ABO Blood Group Reagent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 ABO Blood Group Reagent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Positive Identification
9.6.2 Reverse Identification
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Blood Bank
9.10.3 Research
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Positive Identification
10.6.2 Reverse Identification
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Blood Bank
10.10.3 Research
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Positive Identification
11.6.2 Reverse Identification
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Blood Bank
11.10.3 Research
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Positive Identification
12.6.2 Reverse Identification
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Blood Bank
12.10.3 Research
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Positive Identification
13.6.2 Reverse Identification
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Blood Bank
13.10.3 Research
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 ABO Blood Group Reagent Market: Competitive Dashboard
14.2 Global ABO Blood Group Reagent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CE-Immundiagnostika GmbH
14.3.2 Dominion Biologicals Limited
14.3.3 SHPBC
14.3.4 Brother Biotech
14.3.5 Kinghawk
